Myofacial Pain
Myofacial Pain
Explore linked clinical trials. Standard reference: MESH:M033635910 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment Validation for Myofascial Pain | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-10-01 | NCT07133139 | |
| Lidocaine-prilocaine Cream as Analgesia for In-office Levator Muscle Trigger Point Injections | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pelvic Pain, Signs and Symptoms | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07778043 | |
| Efficacy of PRP Injections in Reducing Pain for Myogenous TMD Patients | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not applicable | 2026-08-05 | NCT07606378 | |
| Measuring Pelvic Floor Muscle Fitness Before and After Treatment | Facial Pain, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pelvic Pain, Sexual Dysfunctions, Psychological, Signs and Symptoms, Urogenital Diseases, female reproductive system disorder, physiological sexual disorder, psychiatric disorder, vaginal disorder, vaginismus | Not yet recruiting | Not applicable | 2026-05-26 | NCT07605598 | |
| Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome | Facial Pain, Musculoskeletal Pain, Myalgia, Myofacial Pain, Myofacial Pain Syndromes, Myofascial Trigger Point Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, fibromyalgia, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myofascial pain syndrome, nervous system disorder, neuromuscular disease, rheumatic disorder | Not yet recruiting | Not applicable | 2026-05-07 | NCT07572994 | |
| Effectiveness of Photobiomodulation for Myofascial Pain in Temporomandibular Disorders | Craniomandibular Disorders, Facial Pain, Jaw Diseases, Mandibular Diseases, Myofacial Pain, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, agnosia, arthropathy, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, perceptual disorders, temporomandibular joint disorder | Not yet recruiting | Not applicable | 2026-03-10 | NCT07460895 | |
| Myofascial Release Wıth Hamstring Shortness | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not applicable | 2025-09-22 | NCT07174258 | |
| Comparison of Treatment Alternatives for Myofascial Pain Causing Central Sensitization | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Not applicable | 2025-05-18 | NCT06869161 | |
| Evaluation of Temporomandibular Joint Condition Post Longstanding Mouth Opening by Rubber Dam | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, rheumatic disorder | Not yet recruiting | Not applicable | 2025-02-18 | NCT06487819 | |
| Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle | Facial Pain, Myofacial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 2 / Phase 3 | 2024-11-12 | NCT06676475 |